Literature DB >> 23928809

Prevalence and prognosis of congestive heart failure in Saudi patients admitted with acute coronary syndrome (from SPACE registry).

Hanan B Albackr1, Khalid F Alhabib, Anhar Ullah, Hussam Alfaleh, Ahmad Hersi, Fayez Alshaer, Khalid Alnemer, Shukri Al Saif, Amir Taraben, Tarek Kashour.   

Abstract

OBJECTIVES: The aim of this study was to assess the prevalence, clinical features, and in-hospital outcomes of heart failure in patients with acute coronary syndrome (ACS).
MATERIALS AND METHODS: The Saudi Project for Assessment of Coronary Events recruited patients admitted with ACS from 17 hospitals in Saudi Arabia from 2005 to 2007. The outcomes of ACS patients with congestive heart failure (CHF) compared with those without CHF were analyzed.
RESULTS: A total of 4523 patients with ACS were identified, of whom 905 (20%) had CHF. Compared with no CHF, patients with CHF were older (62±13.1 vs. 57±12.9 years; P=0.001), less likely to be men (70 vs. 79%; P=0.001), likely to present with non-ST-segment elevation myocardial infarction (48 vs. 36%; P=0.001), likely to have diabetes (71 vs. 54%; P=0.001), hypertension (64 vs. 54%; P=0.001) and previous history of coronary artery disease (53 vs. 43%; P=0.001), and likely to have significant left ventricular systolic dysfunction (left ventricular ejection fraction <35%) (56 vs. 30%; P=0.001). Patients with CHF were less likely to receive in-hospital β-blockers (74 vs. 86%; P=0.001) and a percutaneous coronary intervention (19 vs. 50%; P=0.001). Adjusted in-hospital mortality and cardiogenic shock were higher in the CHF group (odds ratio 4.43, 95% confidence interval 2.52-7.78; and odds ratio 3.51, 95% confidence interval 2.23-5.52), respectively.
CONCLUSION: ACS patients with CHF in the Saudi Project for Assessment of Coronary Events were older, more likely to have more cardiac risk factors, and less likely to be treated with optimum medical treatment on admission. These findings were associated with higher incidence of their in-hospital adverse outcomes. More aggressive treatment is warranted to improve prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23928809     DOI: 10.1097/MCA.0b013e328364d98f

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  3 in total

1.  Retrospective Study of the Association Between Platelet-to-Lymphocyte Ratio in Patients with Acute Coronary Syndrome on Admission to a Rural Referral Center in East Java, Indonesia, and the Incidence of New Symptomatic Heart Failure at 6 Months.

Authors:  Ryan Enast Intan; Firas Farisi Alkaff; Yudi Her Oktaviono; Ricardo Adrian Nugraha; Tan Nicko Octora; Michael Jonatan; Dimas Rio Balti; Fani Suslina Hasibuan; Basuni Radi; Anwar Santoso
Journal:  Med Sci Monit       Date:  2022-03-02

2.  Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry).

Authors:  Hussam AlFaleh; Abdelfatah A Elasfar; Anhar Ullah; Khalid F AlHabib; Ahmad Hersi; Layth Mimish; Ali Almasood; Saleh Al Ghamdi; Abdullah Ghabashi; Asif Malik; Gamal A Hussein; Mushabab Al-Murayeh; Ahmed Abuosa; Waleed Al Habeeb; Tarek S Kashour
Journal:  BMC Cardiovasc Disord       Date:  2016-05-20       Impact factor: 2.298

3.  Quality of Life for Saudi Patients With Heart Failure: A Cross-Sectional Correlational Study.

Authors:  Mohannad Eid AbuRuz; Fawwaz Alaloul; Ahmed Saifan; Rami Masa'deh; Said Abusalem
Journal:  Glob J Health Sci       Date:  2015-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.